At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
CELZ Creative Medical Technology Holdings, Inc.
Not Yet Opened 12-22 16:00:00 EST
2.12
+0.01
+0.47%
盘后2.12
+0.000.00%
19:25 EST
High2.22Low2.10Vol46.48K
Open2.14D1 Closing2.11Amplitude5.53%
Mkt Cap7.41MTradable Cap6.85MTotal Shares3.49M
T/O100.46KT/O Rate1.44%Tradable Shares3.23M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Creative Medical Technology Holdings Inc. Held Annual Shareholder Meeting
Reuters  ·  12-20
Creative Medical Technology Holdings Inc. Held Annual Shareholder Meeting
BRIEF-Creative Medical Technology Completes Enrollment In FDA-Cleared Adapt Trial
Reuters  ·  12-17
BRIEF-Creative Medical Technology Completes Enrollment In FDA-Cleared Adapt Trial
Creative Medical Technology Holdings Completes Enrollment in FDA-Cleared CELZ-201 Trial
Reuters  ·  12-17
Creative Medical Technology Holdings Completes Enrollment in FDA-Cleared CELZ-201 Trial
Creative Medical Technology Holdings, Inc. Completes Enrollment in FDA-Cleared Adapt Trial for Celz-201-Olastrocel, Marking Major Clinical Inflection Point
THOMSON REUTERS  ·  12-17
Creative Medical Technology Holdings, Inc. Completes Enrollment in FDA-Cleared Adapt Trial for Celz-201-Olastrocel, Marking Major Clinical Inflection Point
BRIEF-Creative Medical Technology Holdings Announces World Health Organization Approval Of “Olastrocel”
Reuters  ·  12-02
BRIEF-Creative Medical Technology Holdings Announces World Health Organization Approval Of “Olastrocel”
Creative Medical Technology Holdings Announces World Health Organization Approval of “Olastrocel” as Inn for Lead Allogeneic Cell Therapy Celz-201
THOMSON REUTERS  ·  12-02
Creative Medical Technology Holdings Announces World Health Organization Approval of “Olastrocel” as Inn for Lead Allogeneic Cell Therapy Celz-201
Creative Medical Technology Holdings Awards CEO $100,000 Bonus and CFO $25,000 Bonus
Reuters  ·  11-12
Creative Medical Technology Holdings Awards CEO $100,000 Bonus and CFO $25,000 Bonus
Creative Medical Technology Holdings Inc expected to post a loss of 48 cents a share - Earnings Preview
Reuters  ·  11-05
Creative Medical Technology Holdings Inc expected to post a loss of 48 cents a share - Earnings Preview
Creative Medical Technology Holdings Raises $4.2 Million Through Warrant Exercises and Issues New Warrants
Reuters  ·  11-01
Creative Medical Technology Holdings Raises $4.2 Million Through Warrant Exercises and Issues New Warrants
Creative Medical Technology Holdings, Inc. Ignites Next-Gen Regenerative BioDefense Initiative for U.S. Veterans Exposed to Burn Pits
GlobeNewswire  ·  10-30
Creative Medical Technology Holdings, Inc. Ignites Next-Gen Regenerative BioDefense Initiative for U.S. Veterans Exposed to Burn Pits
Creative Medical Technology Holdings Inc. Announces Date for Annual Stockholders Meeting
Reuters  ·  10-30
Creative Medical Technology Holdings Inc. Announces Date for Annual Stockholders Meeting
Creative Medical announces agreements for warrant exercise for $4.2M proceeds
TIPRANKS  ·  10-29
Creative Medical announces agreements for warrant exercise for $4.2M proceeds
Press Release: Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $4.2 Million Gross Proceeds
Dow Jones  ·  10-29
Press Release: Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $4.2 Million Gross Proceeds
Creative Medical Technology Holdings Issues Letter to Shareholders
GlobeNewswire  ·  10-27
Creative Medical Technology Holdings Issues Letter to Shareholders
Creative Medical Technology Holdings Congratulates 2025 Nobel Laureates for Regulatory T Cell Breakthroughs
GlobeNewswire  ·  10-07
Creative Medical Technology Holdings Congratulates 2025 Nobel Laureates for Regulatory T Cell Breakthroughs
Creative Medical Technology Holdings Secures FDA Fast Track Designation for CELZ-201-DDT - Advancing Breakthrough Therapy for Chronic Lower Back Pain
GlobeNewswire  ·  08-13
Creative Medical Technology Holdings Secures FDA Fast Track Designation for CELZ-201-DDT - Advancing Breakthrough Therapy for Chronic Lower Back Pain
Creative Medical Technology Holdings Inc expected to post a loss of 63 cents a share - Earnings Preview
Reuters  ·  08-06
Creative Medical Technology Holdings Inc expected to post a loss of 63 cents a share - Earnings Preview
Creative Medical Technology Holdings Receives Notice of Allowance for the Prevention and/or Treatment of Type 1 Diabetes Using Modulated Immune Cells
GlobeNewswire  ·  07-17
Creative Medical Technology Holdings Receives Notice of Allowance for the Prevention and/or Treatment of Type 1 Diabetes Using Modulated Immune Cells
Creative Medical Technology Receives US Patent Notice of Allowance for Heart Failure Treatment
MT Newswires Live  ·  07-11
Creative Medical Technology Receives US Patent Notice of Allowance for Heart Failure Treatment

Introduction

Company Name.
Creative Medical Technology Holdings, Inc.
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Creative Medical Technology Holdings, Inc., a commercial stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; and StemSpine, a regenerative stem cell procedure to treat degenerative disc disease. It also develops ImmCelz, an immunotherapy platform for multiple diseases; OvaStem for treatment of female infertility; CELZ-201 to treat Type 1 diabetes; AlloStemSpine for the treatment of chronic lower back pain; and Alova to treat infertility as a result of premature ovarian failure. In addition, the company develops products and services for various indications, including preventing the rejection of transplanted organs, kidney failure, liver failure, heart attack, and Parkinson's disease. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.
Issue price:
--